Paragraph IV Certification

Related by string. Paragraph IV certification * Paragraphs . PARAGRAPH . paragraphs : add paragraph breaks . explanatory paragraph . paragraph breaks / IVs . IVS . IVD : Street Fighter IV . Sid Meier Civilization IV . Elder Scrolls IV Oblivion / Certifications . certifications . certifi cation : Achieves ISO #:# Certification [002] . ISO #:# certification [002] . Common Criteria certification * *

Related by context. All words. (Click for frequent words.) 78 Paragraph IV Notice 72 Paragraph IV 69 Paragraph IV certification 67 Paragraph IV certifications 66 Announces Tentative Approval 65 Abbreviated New 65 Barr ANDA 65 Receives Complete Response 64 ASX BTA 64 Receives FDA Approvable 64 FDA Complete Response 63 Generic Version 62 Orapred ODT 62 FDA Issues Approvable 62 ANDA containing 62 ANDA Filing 62 Submits NDA 61 Nasdaq MYL 61 Morphine Sulfate 61 Bupropion HCl ER 61 Approvable 61 FDA Accepts 61 Generic Version Of 61 Cobalt Pharmaceuticals 61 Drug Application 61 Mylan Receives Approval 61 Receives Approvable Letter 61 Receives Tentative Approval 61 Citizen Petition 60 Biota Holdings Limited 60 Resubmission 60 RAZADYNE 60 Lupin Pharmaceuticals Inc. 60 AMEX CPD 60 Dexilant 60 Testosterone Gel 60 Transcept Pharmaceuticals 60 Caraco Pharma 60 FDA Approvable Letter 59 Anchen Pharmaceuticals Inc. 59 NSE SUNPHARMA 59 OTCBB APCSF 59 PDUFA Date 59 Complete Response 59 Impax Labs 59 Patent Infringement Lawsuit 59 Receives NASDAQ 59 Horizant ™ 59 Supplemental Biologics License Application 59 Drug Submission 59 Substantial Shareholder Interest 59 Ltd Therapeutic Competitors 59 CIP TRAMADOL ER 58 Issues Complete Response 58 Salix Pharma 58 Topiramate Tablets 58 Fund website www.sunamericafunds.com 58 Warner Chilcott Limited 58 Launches Generic Version 58 Drug Application ANDA 58 FastMarkets Ltd 58 Submits Supplemental 58 Milestone Payment 58 NYSE MYL 58 NASDAQ Delisting 58 Javelin Pharma 58 RBXLF 58 Patent Infringement Litigation 58 BioDelivery Sciences 58 Sumatriptan Succinate Tablets 58 Teva Pharmaceuticals USA 58 Company Nasdaq PRGO 58 Receives Notification 58 Generic Protonix 58 Ortho Cept 58 Indevus Pharma 58 Nasdaq IPXL 58 PRAECIS PHARMACEUTICALS INCORPORATED 58 Actavis Elizabeth 58 subsidiary Glenmark Generics 58 Risperidone Oral Solution 57 Receives Anticipated 57 NASDAQ SHPGY 57 TAROF 57 GRALISE 57 Ivax Pharmaceuticals 57 Acknowledges Receipt 57 gets USFDA nod 57 Anchen 57 ANDA filer 57 Kyowa Kirin 57 Terbinafine 57 AMEX IVX LSE IVX.L 57 Inc. Nasdaq SEPR 57 Receives Favorable 57 Teva Parenteral Medicines 57 Release Capsules 57 Taro Receives 57 Biologic License Application 57 Submits Biologics License Application 57 Noven Pharma 57 Distribution Declarations 57 Schizophrenia Drug 57 Preliminary Injunction Against 57 Teva ANDA 57 Late Filing 57 k premarket 57 SHP.L 57 Metformin HCl 57 Director Shareholding 57 Generic Versions 57 Valganciclovir 57 Nasdaq Delisting 56 Nasdaq Delisting Notification 56 NexMed Receives 56 Announces Dismissal 56 nasal calcitonin product 56 Files Investigational 56 Marketing Authorisation Application 56 Celgene Thalomid 56 Sigmapharm 56 OTC IPXL 56 submitted supplemental Biologics 56 Pending Litigation 56 Aurobindo Pharma Limited 56 Par Pharma 56 Receives Fast Track 56 Settle Patent Litigation 56 NASDAQ CPEX 56 ANDA abbreviated 56 Patent Covering 56 USFDA approval 56 Nasacort 56 Files IND 56 PharmaVitae Profile 56 Synthon 56 Package Insert 56 Confirms Patent 56 Therapeutic Competitors Companies 56 NitroMist 56 k Premarket Notification 56 Noon Classifieds & 56 IntelliPharmaCeutics Ltd. 56 enoxaparin sodium injection 56 Teva Pharma 56 Patent Lawsuit 56 Eurand NV EURX 56 SEASONALE R 56 Oracea TM 56 Medicis Pharmaceutical Corporation 56 Extended Release 56 ANDAs 56 Completes Patient Enrollment 55 invalid unenforceable 55 Methylphenidate Transdermal System 55 Receives Milestone Payment 55 Fast Track Status 55 Drug Applications ANDAs 55 Partnering Agreements 55 Nasdaq SPPI 55 Pomerantz Law Firm 55 VISICOL R 55 Aciphex R 55 Amlodipine Besylate 55 FDA approvable letter 55 Stavzor 55 Unsolicited Proposal From 55 Confirms Filing 55 Staff Determination Letter 55 SYCREST 55 Favorable Ruling 55 Receives Tentative FDA 55 Terminate Merger Agreement 55 BRILINTA 55 Receives Unsolicited 55 Reports Receipt 55 Voluntary Dismissal 55 plc Nasdaq WCRX 55 submitted Biologics License 55 Teva Pharm 55 Nasdaq Delisting Notice 55 balsalazide tablet 55 Teva Provides Update 55 Milestone Payments 55 Issued Patent 55 Patent Reexamination 55 #QSB 55 Akorn Inc 55 Files Voluntary 55 Simvastatin Tablets 55 Genpharm 55 Ista Pharmaceuticals Inc 55 Announces Revocation 55 Nasdaq IDEV 55 Marketing Authorisation Application MAA 55 Daytrana ® 55 Complete Response letter 55 markets HP Acthar 55 Announces Mailing 55 Connetics Corporation 55 Nasdaq AVNC 55 NASDAQ Listing 55 NYSE MRX 55 NDA Submission 55 Patent Infringement Case 55 Declaratory Judgment 55 Regains NASDAQ 55 PROTONIX 55 Patent Infringement Suit 55 Default NOD 55 License Option Agreement 55 Oscient Pharmaceuticals 55 Issues Shareholder 55 ANDA 55 VCRT 55 NasdaqCM RPRX today 55 Novel Antibiotic 55 NASDAQ NOVN 55 Nasdaq EPCT 55 Inc. Nasdaq MYL 55 Coalcorp Provides Updated 55 NASDAQ UNIS 55 Submits Response 55 Application BLA 55 sumatriptan succinate injection 55 Investigational Compound 55 Milestone Payment From 55 BioGlue ® 55 Material Fact 55 Ticagrelor 55 Gout Drug 55 Carbidopa Levodopa 55 Explores Strategic Alternatives 55 HSR Waiting Period 55 NASDAQ Listing Requirements 55 b#x# http:/#.#.#.#/fls.geo/PH #x# #.hyahrtzeit 55 Substantial Shareholder Interests 55 therefore therapeutically equivalent 55 Obligatoires 55 Unichem Laboratories Ltd 55 FDA Approval 55 Lorus Therapeutics Announces 54 Teikoku Pharma USA 54 InvaGen 54 euro adhoc Intercell AG 54 Complete Response Letter CRL 54 Dynepo TM 54 Pending Acquisition 54 Akorn Strides 54 TSX SHQ 54 COLAZAL R 54 Earns Milestone Payment 54 Stedesa 54 Nasdaq WCRX 54 Impax generic 54 DOR BioPharma Announces 54 5mg #mg #mg 54 Guaranteed Delivery 54 Initiates Dosing 54 Resale Registration Statement 54 Antidepressant Drug 54 ANDA applicant 54 Liability Lawsuits 54 Penwest Pharma 54 GlaxoSmithKline Imitrex 54 Reexamination Certificate 54 Seasonal Influenza Vaccine 54 BioProspect Limited 54 Delayed Filing 54 Genelabs Technologies 54 Purported Class 54 TSX IEX 54 s Zyflo 54 Release Tablets 54 CorePharma LLC 54 Velaglucerase Alfa 54 AMEX HEB 54 Aztreonam Lysine 54 Transgene Biotek 54 Biological License Application 54 Pandel R 54 Audited Financials 54 Barr Laboratories Inc. 54 Lupin Ltd 54 Settle Litigation 54 Cefprozil 54 Dexamethasone Sodium Phosphate Injection 54 Valortim TM 54 USFDA nod 54 Argatroban 54 Venlafaxine Hydrochloride 54 Phase 2a Trial 54 Amlodipine Besylate Tablets 54 Announce Early Termination 54 Therapeutic Competitors Report 54 Cadila Healthcare Ltd 54 ChemGenex Pharmaceuticals Limited 54 USFDA 54 Par Pharmaceutical 54 Bellus Health 54 Review Strategic Alternatives 54 KVb 54 Terminates Agreement 54 Applications ANDA 54 Arthritis Drug 54 LSE SHP.L 54 Mylan ANDA 54 Pendency 54 IMPAX Laboratories Inc. 54 Synerx Pharma 54 IG HCR ;) CO 54 SOLODYN R 54 Act PDUFA date 54 Presents Positive 54 Orally Disintegrating Tablets 54 Patent Infringement 54 Ucyclyd Pharma Inc. 54 Golar LNG Limited 54 SEASONALE 54 Aldara ® 54 Tiazac 54 DARA logo 54 Ultracet R 54 ASX CXS 54 Hatch Waxman litigation 54 BioSante Pharmaceuticals Announces 54 Cefdinir 54 DOV Pharmaceutical Inc. 54 #KSB 54 balsalazide disodium Capsules 54 Universal Shelf Registration 54 Oxcarbazepine 54 Inhaled Insulin 54 Submits Investigational 54 Sources Sought 54 Alnylam Pharma 54 Files Provisional 54 Patent Infringement Action 54 AMAG Pharma 54 #mg #mg #mg #mg [002] 54 ZEGERID Capsules 54 Non Infringement 54 Nasdaq Listing Requirements 54 Codeine Phosphate 54 Cefprozil tablets 54 NASDAQ CADX 54 Patent Infringement Lawsuit Against 54 Somaxon Pharmaceuticals 54 NYSE KVa KVb 54 LecTec Corporation 54 ANDA approvals 54 Marketing Authorisation 53 Permanent Injunction 53 Product Monograph 53 Nasdaq CYCC Nasdaq CYCCP 53 Regeneron Pharma 53 Nasdaq CADX 53 NYSE BRL 53 Full Prescribing Information 53 NASDAQ NPSP 53 FEMCON FE 53 Option Grants 53 Rehearing En Banc 53 Loramyc ™ 53 Ondansetron Injection 53 TapImmune Inc. 53 ANDA Abbreviated New 53 Weight Loss Drug 53 Files Patent Infringement 53 BTRX 53 Provides Update Regarding 53 Losartan Potassium 53 Abstral ® 53 NGSX 53 Drug Submission NDS 53 KV Pharma 53 Janssen Ortho Inc. 53 Ofloxacin 53 Taglich Brothers Initiates Coverage 53 fentanyl transdermal system 53 Waiver Agreement 53 Shareholder Letter 53 Oxybutynin 53 Patent Validity 53 Aoxing Pharmaceutical Company 53 Quinapril 53 Generic drugmaker 53 Mometasone Furoate 53 Unichem Laboratories 53 Synerx 53 Paladin Labs 53 Patent Upheld 53 FDA Clearance 53 Upcoming Deadline 53 AMEX JAV 53 Receive Milestone Payment 53 GRAS Status 53 Shareholder Lawsuit 53 Inc. OTCBB VODG 53 Premarket Approval Application 53 IOL Chemicals 53 Desloratadine 53 Levoleucovorin 53 Anchen Pharmaceuticals 53 CYCLOSET ® 53 Reveals Receipt 53 Focalin XR ® 53 AstraZeneca Toprol 53 Controlled Release Tablets 53 Patents Covering 53 AMEX ONI 53 Phase IIb Trial 53 Targanta Therapeutics Corporation 53 Ranbaxy Laboratories Limited 53 KINDERHOOK NY BUSINESS WIRE 53 Zegerid OTC 53 disclaimers contained herein 53 pediatric exclusivity 53 FDA Clears 53 Submits IND 53 Para IVs 53 Auxilium Pharma 53 Has Been Filed 53 Receives SFDA Approval 53 Initiates Enrollment 53 Nasdaq Deficiency Notice 53 Recommendation Statement 53 NASDAQ ENZN 53 Fibrocell Science Inc. 53 GRAS notification 53 Aplenzin ™ 53 Polymer Microspheres 53 Oral Suspension USP 53 Xenazine ® 53 Ciclesonide 53 Nasdaq SLXP 53 Creditor Protection 53 Seikagaku Corporation 53 TSX VENTURE TOX 53 Penwest Pharmaceuticals Co. 53 Company NYSE KVa 53 Confirms Validity 53 CEPHALON 53 Replagal TM 53 Kunekt Corporation 53 OPANA ER 53 Rotarix R 53 Action Lawsuits 53 Receives Commitment 53 orally disintegrating 53 Fexofenadine 53 NASDAQ BDSI 53 Filing Status 53 Opana ER 53 Receives Favorable Ruling 53 clopidogrel bisulfate 53 Sumatriptan Succinate 53 Generic Lovenox 53 NUEDEXTA ™ 53 Emisphere Technologies 53 Announces Effectiveness 53 Alphapharm 53 visit www.noven.com 53 CyDex Pharmaceuticals 53 Taisho Pharmaceuticals 53 Settles Litigation 53 Nasdaq ANDS 53 IND Application 53 Sanofi Aventis Allegra 53 NYSE Amex HEB 53 donepezil hydrochloride 53 FACTIVE R gemifloxacin 53 Receives Orphan Drug Designation 53 Amylin Pharma 53 Levetiracetam Tablets 53 NASDAQ Hearings Panel 53 Patent Litigation 53 NASDAQ Deficiency Notice 53 amended #D 53 balsalazide disodium 53 Allegra ® 53 Generic Lipitor 53 Proposed Private Placement 53 Lifts FY# Outlook 53 Receives Notice From 53 ISTA Pharmaceuticals Inc. 52 Ltd. RDY 52 Inspire Pharma 52 RGRX 52 Expanded Indication 52 SFDA Approval 52 TRISENOX R 52 License Application sBLA 52 Ciclopirox 52 Gabapentin Capsules 52 Pfizer Norvasc 52 Terminates Merger Agreement 52 GlaxoSmithKline plc NYSE 52 Wellbutrin XL R 52 Inc. NYSE MYL 52 Corporation Nasdaq CHIR 52 Partnering Guide 52 KV Pharmaceutical Company 52 SILENOR 52 fluvoxamine maleate 52 Bertek Pharmaceuticals 52 Fast Track designations 52 Wins Patent Infringement 52 Announces Favorable 52 Glenmark Pharmaceutical 52 Nasdaq RPRX 52 Announce License Agreement 52 Inc. NASDAQ HITK 52 VXGN 52 Enjuvia 52 Azactam 52 gabapentin capsules 52 Famvir ® 52 ATSX 52 Shire BioChem Inc. 52 Focalin XR R 52 Actavis Totowa 52 SCHWARZ PHARMA 52 Inc. Nasdaq NEOL 52 NASDAQ TARG 52 INTUNIV TM 52 Reuters Generic drugmaker 52 oxybutynin chloride 52 markets COLAZAL 52 Accelerated Approval 52 Board Unanimously Rejects 52 METOZOLV ODT 52 PRNewswire FirstCall Barr Pharmaceuticals 52 Initiates Clinical Trials 52 Staff Deficiency Letter 52 filed Form #b 52 Inc. NASDAQ AGIX 52 #mg dosage strength 52 International SRL BLS 52 Keppra ® XR 52 Obtains Interim 52 adenosine injection 52 Metformin Hydrochloride 52 Patents Upheld 52 Natco Pharma Limited 52 NYSE Amex PTN 52 ANDAs abbreviated 52 Securities andExchange Commission 52 Receives Positive 52 QRxPharma Limited 52 GTC NASDAQ GTCB 52 Nasdaq DVAX 52 Zolpimist 52 Gets Tentative 52 Frova ® 52 Warning Letter 52 Taclonex Scalp R 52 rabeprazole sodium 52 Incorporated URSA Major 52 Naprelan 52 Fortical R 52 Biodel Inc 52 OTCBB ARDM 52 Nationwide Voluntary Recall 52 Backs FY# View 52 Backs FY# Outlook 52 ENZON 52 Warner Chilcott plc 52 ULTRASE 52 Estratest 52 rasagiline tablets 52 Vigorously Defend 52 losartan potassium 52 plc LSE SHP 52 Psoriasis Drug 52 Revises FY# Outlook 52 Receives Orphan Drug 52 IGI Laboratories 52 Marketing Approval PMA 52 sanofi aventis Novartis 52 Medicis Pharma 52 Nasdaq EMIS 52 Epilepsy Drug 52 Similac Recall 52 HCl Injection 52 Announce Shareholder Approval 52 Ltd. Nasdaq TEVA 52 Voluntary Withdrawal 52 MK #B 52 Rheumatoid Arthritis Drug 52 Optimer Pharma 52 KRYSTEXXA TM 52 Topical Gel 52 Deficiency Notice 52 Eszopiclone 52 Solid Oral Dosage 52 MedWatch website 52 Zenith Goldline Pharmaceuticals 52 BRL.N Quote Profile Research 52 Nicomide 52 Authorized Generic 52 ARXT 52 Inc. Nasdaq NSTK 52 Files Shelf Registration 52 Drugmakers AstraZeneca 52 Zensana 52 Expedited Review 52 Nasdaq SVNT 52 Nasdaq Minimum Bid 52 Alnylam Nasdaq ALNY 52 Inc. Nasdaq IMGN 52 CIMZIA r 52 Protalix BioTherapeutics 52 Anemia Drug 52 galantamine hydrobromide 52 CIP ISOTRETINOIN 52 REMINYL 52 LSE SHP NASDAQ SHPGY 52 USOTC SSWC 52 NASDAQ GNMK 52 Oscient 52 APF# NDA 52 Soriatane 52 Nasdaq HALO 52 Nasdaq LGND 52 Cellegesic 52 Q2 Loss Narrows 52 Surfaxin lucinactant 52 Doryx 52 1mg 2mg 52 Inc. Nasdaq CVTX 52 Staff Determination 52 Nasdaq BDSI 52 Extends Tender Offer 52 AMEX IVX 52 CLQMF 52 SWX SPPN 52 Tablets #mg [002] 52 Para IV 52 outlicensed 52 Jiangbo Pharmaceuticals 52 Norgine BV 52 5 lipoxygenase inhibitor 52 Purepac 52 Unsolicited Proposal 52 Listing Compliance 52 Par Pharmaceuticals 52 Provides Shareholder 52 Receives Notice 52 CysDisplay R 52 Azur Pharma 52 Inc. PINKSHEETS RELM 52 Alkaloida 52 Inc. NASDAQ ACUS 52 gabapentin tablets 52 esomeprazole magnesium 52 Competitor Report 52 Announce Filing 52 EPCT 51 Lilly Evista 51 Patent Lawsuit Against 51 sumatriptan injection 51 Nasdaq ENCY 51 NasdaqGM SPPI 51 Nasdaq NBIX 51 Initiates Phase II 51 diazepam rectal gel 51 Generex Biotechnology 51 mg dosages 51 sanofi aventis SNY 51 NASDAQ CYPB 51 Ustekinumab 51 NYSE Amex Listing 51 Aurobindo Pharma 51 Sular formulation 51 Previously Issued 51 Ethinyl Estradiol 51 ALPMF 51 Announces Favorable Ruling 51 Exelon rivastigmine 51 Hatch Waxman Amendments 51 OLEPTRO ™ 51 SPL# Gel vaginal microbicide 51 Alogliptin 51 approvable letters 51 NEXM 51 Endo Pharmaceuticals Nasdaq ENDP 51 Non Binding Letter 51 Approvable Letter 51 Taro Pharma 51 Through Glycoscience ® 51 ISTA Pharmaceuticals 51 Presents Preclinical Data 51 Inc MYL MYL 51 NASDAQ AMLN 51 OTCBB NVDL 51 Product Characteristics 51 NASDAQ TEVA 51 Binding Offer 51 sumatriptan succinate 51 OLEPTRO 51 Tender Offer Solicitation Recommendation 51 hydrochloride tablets 51 Subsidiary Enters 51 Anidulafungin 51 oligonucleotides Manoharan 51 Marketing Authorization 51 Oxytrol R 51 Hydrochloride tablets 51 Pliaglis 51 Issues Boil Water 51 ALDA announces 51 By JAMAAL ABDUL 51 Commences Mailing 51 Stockholder Approval 51 Ipca Laboratories 51 Dementia Related Psychosis 51 Acular 51 Regains Compliance 51 Initiates Clinical 51 Prescribing Information 51 Mg Uk 51 Phase III Clinical Trial 51 pantoprazole sodium 51 visit smith.com 51 Pilocarpine 51 indiplon capsules 51 Sotret 51 submitted Marketing Authorization 51 Legal #.# 51 Periostat R 51 Pre IND 51 #mg #mg [002] 51 GlaxoSmithKline plc GSK 51 Patent Infringement Claims 51 #mg #mg #mg [001] 51 Nasdaq OSCI 51 Catapres TTS 51 Initiates Clinical Trial 51 ZEGERID OTC 51 Epilepsy Drugs 51 NASDAQ CLSN 51 binding Letter 51 SEDAR www.sedar.com www.sedar.com 51 Schedule #C 51 Files Shelf Registration Statement 51 Charles M. Caprariello 51 Completes Enrollment 51 Betaseron ® 51 Cobrek 51 Receives Delisting Notice 51 Oxandrin R 51 Fexofenadine Hydrochloride 51 IPXL 51 Rivastigmine 51 Licenses Patents 51 Receives CE Marking 51 Patent Suit Against 51 Settles Patent Litigation 51 Potential Delisting 51 Voluntarily Withdraws 51 Lupin Pharmaceuticals 51 Filing Requirements 51 mg Tablets 51 Anemia Drugs 51 Markman Hearing 51 Glatiramer Acetate 51 Definitive Proxy Statement Prospectus 51 Positive Opinion 51 FY# Guidance 51 Patient Enrollment 51 Sanvar 51 Praecis 51 Issues Clarification 51 Receives Subpoena 51 Commercialization Agreement 51 Clinical Trial Results 51 FOLOTYN ® 51 Lupin Limited 51 Mircette 51 Piperacillin 51 Glenmark Generics 51 please visit www.eisai.com 51 NASDAQ MYL 51 COLAZAL ® 51 Nasdaq CYCC 51 Shelf Registration 51 Oral Calcitonin 51 generic Lipitor 51 SHEETS AUAYF FRANKFURT A9N 51 Santarus SNTS 51 Nova Measuring 51 Granted Orphan Drug 51 Vitaros R 51 Nycomed GmbH 51 Stalevo 51 Nasdaq ICOS 51 Employment Inducement Awards 51 Tibotec Pharmaceuticals Ltd. 51 AMEX PLX 51 Patent Infringement Suit Against 51 Flamel Technologies Announces 51 Ohr Pharmaceutical Inc. 51 NASDAQ IPXL today 51 NYSE TSX BVF 51 Gets FDA Clearance 51 subsidiary Mylan Pharmaceuticals 51 NASDAQ SLXP 51 Rotarix ® 51 Tablets USP 51 VIVITROL ® 51 Proxy Proposals 51 Silodosin 51 Q2 Adj 51 Announces Spin Off 51 OTC IPXL today 51 Receives Approvals 51 Proquin XR 51 Merz Pharma GmbH 51 Merger Transaction 51 DOV Pharmaceutical 51 NASDAQ Minimum Bid 51 Fosphenytoin 51 Subsidiary Files 51 PXSL 51 Miacalcin 51 Ondansetron 51 Novartis VIRT X 51 Drug Fails 51 Migraine Drug 51 NASDAQ Listing Qualification 51 DepoMed 51 Sunesis Pharma 51 Bulletin des Annonces 51 No Objection Letter 51 tramadol HCl 51 Voluntarily Delist 51 Receives Delisting Notification 51 Alkem Laboratories 51 Jiangbo Pharmaceuticals Inc. 51 Nasdaq ACHN 51 Valacyclovir 51 Drug Candidate 51 sumatriptan succinate tablets 51 Somatuline R Autogel R 51 Velac 51 Intellipharmaceutics 51 Receives Approval From 51 IND Filing 51 OIIM 51 Present Preclinical Data 51 NASDAQ NOVN today 51 Andrx Pharmaceuticals 51 Ursodiol 51 Adventrx Pharmaceuticals 51 HP Acthar R 51 FDA Orphan Drug 51 Licenses Novel 51 Sycrest 51 Nasdaq MNKD 51 generic Norvasc 51 Duramed Pharmaceuticals 51 SEASONIQUE R 51 Sanctura XR 51 Romiplostim 51 PRNewswire FirstCall SkyePharma PLC 51 Files Definitive Proxy 51 Pennsaid R 51 Strides Arcolab Ltd 51 Eurand NV 51 Orphan Drug designations 51 Sun Pharmaceutical Industries 51 ANDA filings 51 Glucotrol XL 51 Vitaros 51 Q4 Profit Decreases 51 Exclusive License 51 Roxane Laboratories 51 NYSE Amex RGN 51 Cholesterol Lowering Drug 51 Offer Prospectus 51 Nasdaq IMGN 51 Completes Tender Offer 51 Inc. NASDAQ APCVZ 50 TRANSDUR ™ 50 Kodroff PC Announces 50 ANDA submission 50 Glucophage XR 50 topical gel formulation 50 Receives Notice Related 50 Anika Therapeutics 50 Visicol 50 NASDAQ PGNX 50 Contrave NDA 50 Regulatory Approvals 50 Provisional Patent 50 DYAI 50 Reaffirms FY# Guidance 50 MacroChem Corporation 50 GTC Nasdaq GTCB 50 Duramed Pharmaceuticals Inc. 50 Cautionary Factors 50 Alnylam ALNY 50 Action Proposed Settlement 50 Sustained Release 50 JHP Pharmaceuticals LLC 50 Delays Filing 50 Prostate Cancer Vaccine 50 CARBOSOME 50 Palatin Technologies Inc. 50 Allegra D# 50 Extended Release Tablets 50 FY# Loss Narrows 50 Allos logo 50 Maleate 50 Tenofovir Disoproxil Fumarate 50 Combunox 50 PLAVIX ® 50 Ceftin 50 DDMAC 50 NASDAQ DRRX 50 AstraZeneca Nexium 50 Biotie 50 Endo Pharmaceuticals NASDAQ ENDP 50 Zyflo CR 50 pulls Darvon painkiller 50 Lamictal ODT 50 Announces Debt Settlement 50 Teva TEVA 50 Mirtazapine 50 Trelstar R 50 deathnotices@thenewsstar.com 50 Counterclaim 50 Protiva Biotherapeutics 50 sNDAs 50 Onyx Pharma 50 venlafaxine hydrochloride 50 Milberg Weiss Announces 50 AMEX RGN www.regenerx.com 50 Elestrin TM 50 CIP Fenofibrate 50 Nasdaq NPSP 50 Sanvar R 50 Nasdaq ALGN 50 Tamoxifen Citrate 50 mesylate tablets 50 HCl capsules 50 OTC ZEGERID 50 Reaffirms FY# Outlook 50 Violation NOV 50 Q2 Loss Widens 50 Celebrations PO Box 50 Napo Pharmaceuticals 50 Nasdaq SNTS 50 abacavir sulfate lamivudine 50 GSK '# 50 Ticker Symbol Change 50 Inc. OTC TOFS 50 CORLUX CORT # 50 Nascobal R 50 Commence Tender Offer 50 Transcept Pharma 50 supplemental biologics 50 ER Tablets 50 Previously Disclosed 50 subsidiary Biovail Laboratories 50 Risk Warning 50 Files Preliminary Proxy 50 BioMarin Huxley Ltd. 50 Rescula 50 OGXI 50 ALLEGRA ® 50 Amex ANX 50 Zars Pharma 50 called Microstructure Chromatograph 50 inspectional observations 50 Unsolicited Tender Offer 50 BioSante Pharmaceuticals 50 inhalation aerosol 50 Q4 Loss Widens 50 Zenpep 50 NASDAQ FLML 50 Executes Letter 50 Nasdaq NOVN 50 Final Approval 50 Presents Positive Preclinical 50 Liprotamase 50 Files Annual Report 50 Nasdaq OSIP 50 please email chris@chfir.com 50 Submits Application 50 Agis Industries 50 Going Concern Qualification 50 Mucotrol 50 Levothyroxine Sodium 50 Nasdaq IDRA 50 Not Approvable 50 Nasdaq ADLR 50 Underreported Income

Back to home page